Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01160458 · OUTCOME

Overall Survival (OS)

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy · Source last updated 2018-04-10

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Months
Interval / dispersion
95% Confidence Interval
Time frame
To study completion, an average of 3 years

What was measured

Overall survival is the time interval from the start of treatment to the date of death.

Analysis population: One participant withdrew from the study and was excluded from the analysis.

Groups in this outcome

IMC-A12 Monotherapy in Patients

20 mg/kg intravenous over 60 minutes or not to exceed 25 mg/minute once every 3 weeks (+ or -1 day cycle 3 and beyond)

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
IMC-A12 Monotherapy in Patients19

Reported measurements

Source class 1
Values in Months · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
IMC-A12 Monotherapy in Patients5.5Not reported2.112.2Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        2.1
        upper Limit
        12.2
        value
        5.5
denoms
  1. counts
    1. group Id
      OG000
      value
      19
    units
    Participants
description
Overall survival is the time interval from the start of treatment to the date of death.
dispersion Type
95% Confidence Interval
groups
  1. description
    20 mg/kg intravenous over 60 minutes or not to exceed 25 mg/minute once every 3 weeks (+ or -1 day cycle 3 and beyond)
    id
    OG000
    title
    IMC-A12 Monotherapy in Patients
param Type
MEDIAN
population Description
One participant withdrew from the study and was excluded from the analysis.
reporting Status
POSTED
time Frame
To study completion, an average of 3 years
title
Overall Survival (OS)
type
SECONDARY
unit Of Measure
Months

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice